Insights on Global Infectious Disease Diagnostics Market Size & Share Calculated to Reach USD 42013.2 Million by 2027, Exhibit a CAGR of 6.9%: Report by Zion Market Research

PR Newswire
Wednesday, May 18, 2022 at 9:30am UTC

Insights on Global Infectious Disease Diagnostics Market Size & Share Calculated to Reach USD 42013.2 Million by 2027, Exhibit a CAGR of 6.9%: Report by Zion Market Research

PR Newswire

NEW YORK, May 18, 2022 /PRNewswire/ -- As per Zion Market Research study, The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.2 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period. The report analyzes the digital remittance market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

 

Zion_Market_Research_Logo

Key Industry Insights & Finding of the Infectious Disease Diagnostics Market Reports:

  • As per the analysis shared by our research analyst, the Infectious Disease Diagnostics Market is expected to grow annually at a CAGR of around 6.9 % (2022-2028).
  • Through the primary research, it was established that the Infectious Disease Diagnostics Market was valued approximately USD 28152.7 Million in 2021 and is projected to reach to roughly USD 42013.2 Million by 2028.
  • The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices.
  • Asia-Pacific is expected to register the highest CAGR from 2021 to 2028, owing to an increase in the prevalence of infectious diseases, a rise in demand for early diagnosis, development of healthcare infrastructure, technological advancement in diagnostic testing, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Zion Market Research published the latest report titled as  "Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments, and Software & Services), By Type of Testing (Laboratory Testing, and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies), By Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028." into their research database.

Infectious Disease Diagnostics Market: Overview

Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens, and molecular methods. Diagnostic tests are crucial for diagnosing diseases and for the overall improvement of global health. Traditional methods were time-consuming and often produced inaccurate results. This led to the emergence of quick, accurate, and portable testing products in the market.

The growth of the infectious disease diagnosis market is mainly due to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, Swine Flu, etc.; growing awareness for early detection using specific diagnostic tests; progress in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized testing services.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/infectious-disease-diagnostics-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 190 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

Industry Dynamics:

Infectious Disease Diagnostics Market: Growth Dynamics

Drivers:  The global prevalence of infectious diseases and onset of COVID-19.

The prevalence of infectious diseases in developed and developing regions positively influenced the growth of the infectious disease diagnostics market and is expected to be a major factor in its growth during the forecast period. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, alongside the growing trend for preventive medicine, are expected to drive the demand for the infectious disease diagnostics market.

Restraints: Lack of accuracy of point of care diagnostic tests and Unfavorable reimbursement scenario.

In underdeveloped and low-income regions, lack of training among clinicians and poor accessibility has led to decreased adoption of Infectious Disease Diagnostics test kits. Moreover, Inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. A major challenge that most diagnostic companies face in commercializing their tests is getting health insurers to pay for them.

Directly Purchase a Copy of the Report at https://www.zionmarketresearch.com/buynow/su/infectious-disease-diagnostics-market

Global Infectious Disease Diagnostics Market: Segmentation

  • The global infectious disease diagnostics market is segregated based on product, type of testing, technology, disease type, and end-user.

By product, the global market is distinguished into Reagents, Kits, and Consumables, Instruments, and Software & Services. In 2020, the reagents, kits, and consumables segment accounted for the largest share of this market. The driving factor for the growth of this segment was the frequent purchase of these products due to their recurrent usage.

By technology, the global market is bifurcated into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies. The immunodiagnostics segment is projected to account for the largest share. This can be attributed to the increasing use of immunoassays in COVID-19 testing, POC infectious disease testing, the development of novel immunodiagnostic tests, and the rising trend of automation.

Get More Insight before Buying at : https://www.zionmarketresearch.com/inquiry/infectious-disease-diagnostics-market

List of Key Players of  Infectious Disease Diagnostics Market:

  • Abbott Laboratories (US)
  • F. Hoffmann-La Roche Ltd(Switzerland)
  • bioMérieux SA (France)
  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)
  • Quidel Corporation(US)
  • Hologic Inc. (US)
  • Siemens Healthineers AG (Germany)
  • Becton Dickinson and Company (US)
  • PerkinElmer Inc. (US)
  • QIAGEN (Netherlands)
  • Grifols S.A. (Spain)
  • DiaSorin S.p.A (Italy)
  • Bio-Rad Laboratories Inc. (US)
  • Sysmex Corporation (Japan)
  • Ortho Clinical Diagnostics (US)
  • Luminex Corporation (US)
  • Meridian Bioscience (US)
  • Genetic Signatures (Australia)
  • OraSure Technologies (US)
  • Trinity Biotech Plc. (Ireland)
  • Chembio Diagnostic Systems Inc. (US)
  • Seegene Inc. (South Korea)
  • Co-Diagnostics Inc. (US)
  • ELITechGroup (France)
  • Epitope Diagnostics Inc. (US)
  • Trivitron Healthcare (India)
  • Meril Life Sciences Pvt. Ltd. (India)
  • InBios International Inc. (US)
  • ABACUS Diagnostica Oy (Finland)

Key questions answered in this report:

  • What are the growth rate forecast and market size for Infectious Disease Diagnostics Market?
  • What are the key driving factors propelling the Infectious Disease Diagnostics Market forward?
  • What are the most important companies in the Infectious Disease Diagnostics Market Industry?
  • What segments does the Infectious Disease Diagnostics Market cover?
  • How can I receive a free copy of the Infectious Disease Diagnostics Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 28152.7 Million

Revenue forecast in 2028

USD 42013.2 Million

Growth Rate

CAGR of almost 6.9 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Million), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/2145

Free Brochure: https://www.zionmarketresearch.com/requestbrochure/infectious-disease-diagnostics-market

Recent Developments

  • In May 2021, Torus Biosystems revealed the USD 25 million series-A financing to advance infectious disease diagnostics across healthcare settings.
  • In March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Regional Dominance:

  • Improve the accessibility of diagnostic services to enhance the prevention.

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period due to the rise in occurrence of infectious diseases, presence of key players, development of the healthcare sector, presence of national clinical laboratories, advancement in technology for diagnostic instruments in the region, and an increase in awareness among the population regarding the availability of treatment devices. However, Asia-Pacific is expected to register the highest CAGR from 2021 to 2028, owing to an increase in the prevalence of infectious diseases, a rise in demand for early diagnosis, development of healthcare infrastructure, technological advancement in diagnostic testing, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Global Infectious Disease Diagnostics Market is segmented as follows:

Infectious Disease Diagnostics Market: By Product Outlook (2022-2028)

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market: By Type of Testing Outlook (2022-2028)

  • Laboratory Testing
  • POC Testing

Infectious Disease Diagnostics Market: By Technology Outlook (2022-2028)

  • Immunodiagnostics
  • Clinical Microbiology
  • PCR
  • INAAT
  • DNA Sequencing & NGS
  • DNA Microarrays
  • Other technologies

Infectious Disease Diagnostics Market: By Disease Type Outlook (2022-2028)

  • COVID-19
  • HIV
  • HAIs
  • Hepatitis
  • CT/NG
  • HPV
  • TB
  • Influenza
  • Other Infectious Diseases

Infectious Disease Diagnostics Market: By End-User Outlook (2022-2028)

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

Infectious Disease Diagnostics Market: By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release For Infectious Disease Diagnostics Market: https://www.zionmarketresearch.com/news/global-infectious-disease-diagnostics-market

Browse Other Related Research Reports from Zion Market Research

  • Micro Computed Tomography Market - Global Industry Analysis: The global Micro Computed Tomography Market accrued earnings worth approximately 157 (USD Million) in 2020 and is predicted to gain revenue of about 328 (USD Million) by 2028, is set to record a CAGR of nearly 7.8% over the period from 2021 to 2028.
  • Blood Ketone Meter Market - Global Industry Analysis: The global Blood Ketone Meter Market accrued earnings worth approximately 289 (USD Million) in 2021 and is predicted to gain revenue of about 578(USD Million) by 2028, is set to record a CAGR of nearly 6.9% over the period from 2022 to 2028.
  • Orthopedic Navigation Systems Market - Global Industry Analysis: The global Orthopedic Navigation Systems market accrued earnings worth approximately 2.1(USD Billion) in 2020 and is predicted to gain revenue of about 7.3 (USD Billion) by 2028, is set to record a CAGR of nearly 14.7% over the period from 2021 to 2028.

Browse through Zion Market Research's coverage of the Global Medical Device Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/

Cision View original content:https://www.prnewswire.com/news-releases/insights-on-global-infectious-disease-diagnostics-market-size--share-calculated-to-reach-usd-42013-2-million-by-2027--exhibit-a-cagr-of-6-9-report-by-zion-market-research-301549930.html

SOURCE Zion Market Research